Pfizer Inc.

COVID-19 vaccine rollout in U.S. for children under six to pick up pace in coming days, official says

U.S. FDA panel backs COVID-19 vaccines for children as young as six months

Will COVID-19 vaccines become seasonal like the flu shot?

FDA says Pfizer COVID-19 shot appears effective for kids under 5

Pfizer’s Paxlovid reduces COVID-19 risk in seniors regardless of vaccine status, study finds

Pfizer seeks U.S. authorization of COVID-19 vaccine for children under age of five

Canada authorizes Pfizer COVID-19 booster for 16 and 17-year-olds

Pfizer to exit GSK’s consumer health arm Haleon after spin-off

Pfizer to sell all its patented drugs at non-profit price in low-income countries

Three doses of COVID-19 vaccine elicit good response in children under five: Pfizer-BioNTech

Use of Pfizer COVID-19 antiviral Paxlovid up 315 per cent: U.S. health department

Pfizer to spend $11.6-billion to buy remaining portion of migraine treatment maker Biohaven

The close: TSX flirts with correction territory as commodity prices fall

Pfizer, Moderna and other COVID-19 vaccine makers shift focus to boosters

U.S. limits use of J&J’s COVID-19 vaccine due to blood clot risks

Alberta allows physicians, other health-care workers to prescribe Paxlovid for COVID

Moderna forecasts higher COVID-19 vaccine sales in second half of 2022

Pfizer maintains sales forecasts for its COVID-19 vaccine, pill as pandemic curbs ease

WHO backs Pfizer’s oral COVID therapy for high-risk patients

Quebec says mRNA COVID-19 vaccines preferable to Medicago in most circumstances